Oxazolidine Formation, or Loss of Acid, from Attempted Fluorination of Amide Side-Chain in 2-Nitroimidazoles

2018 ◽  
Vol 55 (6) ◽  
pp. 1444-1449
Author(s):  
Ian R. Baird ◽  
Brian O. Patrick ◽  
Kirsten A. Skov ◽  
Brian R. James
Keyword(s):  
Author(s):  
Loek A. M. Bastiaansen ◽  
Ton J. M. Vermeulen ◽  
Henk M. Buck ◽  
Wilberth J. J. Smeets ◽  
Jan A. Kanters ◽  
...  

2018 ◽  
Vol 20 (5) ◽  
pp. 3411-3423 ◽  
Author(s):  
S. Habka ◽  
W. Y. Sohn ◽  
V. Vaquero-Vara ◽  
M. Géléoc ◽  
B. Tardivel ◽  
...  

The anchoring properties of an asparagine (Asn) residue to its local backbone environment in turn model peptides is characterized using gas phase laser spectroscopy and compared to crystallized protein structures.


1977 ◽  
Vol 23 (2) ◽  
pp. 169-174 ◽  
Author(s):  
W A Ratcliffe ◽  
S M Fletcher ◽  
A C Moffat ◽  
J G Ratcliffe ◽  
W A Harland ◽  
...  

Abstract We raised high-titre antisera to two LSD-bovine serum albumin conjugates, one linked via the indole nitrogen, the other via the amide side-chain. The antisera were specific for different parts of the LSD molecule, as demonstrated by cross-reactivity studies with LSD, its metabolites, ergot alkoloids, and closely related compounds. The antisera were used to develop a double-antibody radioimmunoassay with a detection limit of about 0.4 mug of LSD per liter of unextracted urine or serum. We saw no nonspecific interference by urine, serum, or from a series of commonly used drugs. There was good correlation between immunoassay values obtained with the two antisera (r = 0.91). However, the antiserum linked via the indole nitrogen gave consistently higher results for samples from persons who had taken LSD, owing to greater cross-reactivity with LSD metabolites. Radioimmunoassay by use of two such antisera is a more specific screening procedure for LSD abuse than has been available previously. In addition, antisera cross-reacting with LSD metabolites allow measurement of these compounds, for which there is no satisfactory method at the concentrations found in biological fluids in man.


2012 ◽  
Vol 22 (8) ◽  
pp. 2775-2779 ◽  
Author(s):  
Hiroshi Nagase ◽  
Junko Akiyama ◽  
Ryo Nakajima ◽  
Shigeto Hirayama ◽  
Toru Nemoto ◽  
...  
Keyword(s):  

IUCrData ◽  
2017 ◽  
Vol 2 (6) ◽  
Author(s):  
Zhiqiang Guo ◽  
Yakong Wang ◽  
Ying Xu ◽  
Xuehong Wei

The title compound, C16H18N4O2Se2, is centrosymmetric. The dihedral angle between the pyridine ring and the amide side chain is 56.20 (16)°. In the crystal, a weak C—H...O interaction links the molecules into [010] chains.


2018 ◽  
Vol 122 (19) ◽  
pp. 4956-4971 ◽  
Author(s):  
Jon Uranga ◽  
Jon I. Mujika ◽  
Rafael Grande-Aztatzi ◽  
Jon M. Matxain

Author(s):  
Ardhendu Sekhar Giri ◽  
Animes Kumar Golder ◽  
Sankar Chakma

Abstract In this study, the aim was to explore the effectiveness of the UV/H2O2 photolysis (UVP) process in terms of antimicrobial activity reduction and increasing the mean oxidation number of carbon (MONC) under the degradation of chloramphenicol (CHPL) drug. CHPL degradation kinetics and the effects of foreign anions on CHPL degradation were explored in this study. The order of the inhibition effect was found as Cl− > NO3− > HCO3− due to their different in HO• radical scavenging capacity. A pseudo-first-order model for CHPL degradation was well established, and the rate constant (kobs) was 2.93 × 10−2 min−1 (R2 = 0.98) in UVP. Thirteen intermediate products were detected in MS-chromatogram and were identified through different proposed degradation pathways. The cleavage of the amide side chain in CHPL was more effective in CHPL degradation due to an electrophilic attacks by HO. radicals on it. The inactivation rates of E. coli were decreased due to the reduction of -NO2 group into -NH2 functional group in CHPL that leads to the production of low toxic compounds on CHPL degradation.


Synthesis ◽  
2010 ◽  
Vol 2011 (01) ◽  
pp. 69-72
Author(s):  
Sławomir Makowiec ◽  
Karolina Janikowska ◽  
Natalia Pawelska
Keyword(s):  
One Step ◽  

2009 ◽  
Vol 22 (3) ◽  
pp. 229-233 ◽  
Author(s):  
Aura Tintaru ◽  
Laurence Charles ◽  
Petr Milko ◽  
Jana Roithová ◽  
Detlef Schröder

Sign in / Sign up

Export Citation Format

Share Document